Leslie L Iversen - Net Worth and Insider Trading

Leslie L Iversen Net Worth

The estimated net worth of Leslie L Iversen is at least $615,965 dollars as of 2024-05-05. Leslie L Iversen is the Director of ACADIA Pharmaceuticals Inc and owns about 36,127 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $615,965. Details can be seen in Leslie L Iversen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Leslie L Iversen has not made any transactions after 2016-04-18 and currently still holds the listed stock(s).

Transaction Summary of Leslie L Iversen

To

Leslie L Iversen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leslie L Iversen owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .

Click here to see the complete history of Leslie L Iversen’s form 4 insider trades.

Insider Ownership Summary of Leslie L Iversen

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2016-04-18 director

Leslie L Iversen Latest Holdings Summary

Leslie L Iversen currently owns a total of 1 stock. Leslie L Iversen owns 36,127 shares of ACADIA Pharmaceuticals Inc (ACAD) as of April 18, 2016, with a value of $615,965.

Latest Holdings of Leslie L Iversen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2016-04-18 36,127 17.05 615,965

Holding Weightings of Leslie L Iversen


Leslie L Iversen Form 4 Trading Tracker

According to the SEC Form 4 filings, Leslie L Iversen has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 33,697 shares on April 18, 2016, which brought Leslie L Iversen around $1 Million.

Insider Trading History of Leslie L Iversen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Leslie L Iversen Trading Performance

GuruFocus tracks the stock performance after each of Leslie L Iversen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leslie L Iversen is 240.24%. GuruFocus also compares Leslie L Iversen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leslie L Iversen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Leslie L Iversen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Leslie L Iversen

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 30.18
Relative Return to S&P 500(%) 29.23

Leslie L Iversen Ownership Network

Ownership Network List of Leslie L Iversen

No Data

Ownership Network Relation of Leslie L Iversen


Leslie L Iversen Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Leslie L Iversen is the director of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Leslie L Iversen made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 312,332 shares made by Stephen Davis , a net sale of 35,661 shares made by Brendan Teehan , and a net sale of 19,096 shares made by James Kihara .

In summary, during the past 3 months, insiders sold 89,116 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 89,116 shares. During the past 18 months, 452,970 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 443,552 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Leslie L Iversen Mailing Address

Above is the net worth, insider trading, and ownership report for Leslie L Iversen. You might contact Leslie L Iversen via mailing address: C/o University Of Oxford, Mansfield Road, Oxford X0 Ox1 3qt.

Discussions on Leslie L Iversen

No discussions yet.